Engineered luciferases and luciferins have dramatically expanded the scope of bioluminescence imaging in recent years. Multicomponent tracking remains challenging, though, due to a lack of streamlined methods to visualize combinations of bioluminescent reporters. Here we report a strategy for rapid, multiplexed imaging with a wide range of luciferases and luciferins. Sequential addition of orthogonal luciferins, followed by substrate unmixing, enabled facile detection of multiple luciferases in vitro and in vivo. Multicomponent imaging in mice was also achieved on the minutes-to-hours time scale, a vast improvement over conventional protocols.
MAIN
Bioluminescence imaging (BLI) is a popular technique for tracing cells and other biological features in heterogeneous environments, including whole animals. 1 BLI relies on genetically encoded luciferase enzymes and luciferin substrates for photon production. Because mammalian tissues do not normally glow, BLI enables sensitive imaging in vivo. As few as 1-10 cells can be reliably detected using optimized probes in subcutaneous models. For these reasons, BLI has long been a go-to technique for monitoring physiological processes in rodents. [2] [3] [4] More recent advances are further enabling studies in non-human primates and other large organisms. [5] [6] While ubiquitous, BLI applications in vivo typically track only one cell type or feature at a time. 2 A spectrum of bioluminescent reporters exists, but discriminating them based on wavelength alone is challenging. 3 In fact, most applications featuring two BLI reporters combine firefly luciferase (Fluc) and Renilla luciferase (Rluc), two enzymes that use different substrates. [7] [8] Multicomponent imaging with Fluc and Rluc in vivo, though, often requires multiple hours, if not days. The bioluminescent substrates are typically administered at saturating doses to maximize photon output, and the first probe must clear prior to administering the second. In principle, dozens of other naturally occurring luciferases and luciferins could be employed for multiplexed BLI. 9 In practice, though, most of these enzymes and substrates are ill-suited for in vivo use.
We aimed to address the need for better probes and more practical imaging protocols for multicomponent BLI. Our approach builds on the expanding toolbox of orthogonal bioluminescent reagents. 3 These probes comprise genetically modified luciferases that are responsive to chemically unique luciferins. 5, [10] [11] [12] [13] A handful of the orthogonal enzymes can be readily discriminated in cells and mouse models based on selective substrate use. [10] [11] Like Fluc and Rluc, though, traditional applications of the engineered reporters require long times (hoursto-days) for complete image capture. 11 Here we report a method to rapidly resolve orthogonal bioluminescent probes on the minutes-to-hours time scale. The approach is broadly applicable and scalable to multiple reporters, enabling facile multiplexed bioluminescence imaging.
We hypothesized that rapid BLI could be achieved via sequential substrate administration and serial image acquisition. Light outputs would build over time, with each luciferin application resulting in stronger signal. A final processing step 14 would unmix the images (Fig. 1a ). This approach fundamentally differs from conventional optical imaging, in that wavelength, lifetime, and other traditional parameters are less significant. The probes must simply be substrate resolved (i.e., orthogonal) and intensity resolved (Fig 1b) . Substrate resolution minimizes cross talk between the probes. Intensity resolution ensures that signal can be "layered in": as successively brighter probes are imaged, residual signal from dimmer, earlier images becomes part of the background. No time is required for substrate clearance. If the bioluminescent probes are not intensity resolved, the targets are indistinguishable.
Similar "layering" approaches have vastly expanded fluorescence detection of gene transcripts 15 and other cellular features [16] [17] in recent years. To identify suitable probes for rapid BLI, we focused on two previously reported orthogonal luciferins: 4'-BrLuc and D-luciferin (D-luc, Fig. 1c ). 11 These substrates are bright, bioavailable, and accessible in large quantities. We also previously identified mutant luciferases that could differentiate the analogs. 11 While orthogonal, these pairs were engineered for maximum brightness and not built with intensity resolution in mind. To identify orthogonal luciferases that exhibited a range of photon outputs, we screened a small panel of mutants known to process C4'-modified analogs ( Fig S1) . Screens were performed both in vitro and in vivo. In the latter case, DB7 cells stably expressing mutant luciferases were implanted in mice. 4'-BrLuc and D-luc were administered sequentially. The most orthogonal and intensity resolved pair comprised mutants 51 and 37 ( Fig S2) , which we subsequently named Pecan and Cashew, respectively. Bioluminescent signal from 4'-BrLuc/Pecan is orders of magnitude lower than D-luc/Cashew, meaning that the two pairs are intensity resolved and amenable to rapid sequential imaging (Figs 1c and S2). 4'-BrLuc can be administered first (to illuminate Pecan), followed immediately by D-luc (to illuminate Cashew). Since Cashew signal is brighter than Pecan, the images can be readily unmixed.
To evaluate the reporters for rapid multicomponent BLI, we performed a series of in vitro experiments. Pecan and Cashew-expressing cells were ruptured, and lysates were distributed across black-well plates. 4'-BrLuc was initially administered to each well, and an image of the plate was acquired (Fig 2a) . D-Luc was then immediately added to the same wells, and a second image was acquired. Because light output from Cashew is brighter, the Pecan signal falls entirely within the noise of the second image. False colors were assigned to each reporter. The images were then overlaid and a linear unmixing algorithm was employed to determine the relative quantities of each mutant. In all cases, the measured signal correlated linearly with probe concentration (Fig 2b) . Signal outputs from mixed lysate samples were also co-linear with samples comprising a single luciferase, indicating minimal signal crosstalk (as expected for orthogonal probes). Rapid imaging required the dimmest reporter to be visualized first ( Fig S3) . The unmixing algorithm is not necessary when the second target is more abundant than the first. 15 When the second target (associated with the "brightest" luciferase) is in low abundance, though, the algorithm is crucial for proper image interpretation. Unmixing ensures that residual signal from the first image is eliminated and doesn't interfere with the subsequent image ( Fig S4 and Supplementary Discussion). Since the relative abundance of multiple targets is unknown in a given experiment, the algorithm would be employed in all cases by the end user. The "layering in" approach was applicable to several classes of luciferases and luciferins in vitro ( Fig  S5) . Multiple mammalian cell populations could also be visualized in a single imaging session ( Fig S6) .
The rapid multicomponent BLI protocol was further applied in vivo. Pecan-and Cashewexpressing cells were mixed in varying ratios and implanted in mice (10 6 cells per site, Fig 2c) . Upon injection of 4'-BrLuc, Pecan-expressing cells were readily visualized (Fig 2d) . Prior to substrate clearance, the brighter luciferin (D-luc) was injected. Signal was then observed from Cashew-expressing cells. Substrate unmixing revealed the expected distributions of Cashewand Pecan-expressing cells (Figs 2d, S7). Notably, the two-component imaging session was complete in ~1 hour, a significant improvement from the 6-24 h imaging window typically used with other substrate-resolved probes. 11 The relative composition of the cell masses could be readily visualized. Like conventional BLI, the unmixing algorithm cannot provide absolute quantification of bioluminescent signals in animals. Rather, the relative amounts of signal are easily discerned and tracked. These measures are often paramount in optical imaging in vivo and similar intensiometric measures are routinely used in imaging with fluorescent sensors. [18] [19] Rapid BLI is generalizable to multiple luciferase reporters that use unique substrates and exhibit a range of intensities. To demonstrate with a set of three probes, we used Cashew and Pecan in combination with Antares, a recently reported marine luciferase variant. 20 Cashew and Pecan derive from the insect luciferase family, and are thus immediately orthogonal to luciferases (like Antares) that use vastly distinct luciferins (in this case, furimazine). 6 Antares also exhibits markedly faster substrate turnover than Cashew, rendering it brighter and intensity resolved from the other two reporters. We thus reasoned that the three orthogonal luciferases could be rapidly differentiated by first applying 4'-BrLuc, followed by D-luc, then furimazine to layer in signal from Pecan, Cashew, and Antares, respectively. When the cells were combined and imaged together, the three reporters could be rapidly visualized (<15 minutes) following sequential substrate addition (Fig 3) . Triplet imaging was also readily achieved using other combinations of engineered and native luciferases ( Fig S8) . Historically, triple-component BLI has been difficult to execute due to a lack of streamlined protocols. 21 In conclusion, we developed a strategy for rapid multicomponent bioluminescence imaging based on substrate unmixing. This method takes advantage of both substrate and intensity resolution to resolve mixtures of reporters. We validated the approach in lysate, live cells, and mouse models. Probe differentiation is unaffected by tissue depth or location, parameters that have historically hindered efforts to resolve colors in large organisms. Like conventional BLI, the unmixing algorithm enables relative amounts of signal to be tracked over time in physiologically relevant environments. We anticipate that this approach will enable a range of applications, including monitoring multiple cell types and gene expression profiles. The development of additional intensiometric probes will further increase the number of bioluminescent probes that can be rapidly imaged in tandem. An expanded toolkit for BLI will enable longstanding questions regarding multicellular interactions to be addressed.
MATERIALS AND METHODS

Reagents
All reagents purchased from commercial suppliers were of analytical grade and used without further purification. 4'-BrLuc, 4'-MorphoLuc, 7'-MorPipLuc, and 7'-DMAMeLuc were prepared and used as previously described. [10] [11] General bioluminescence imaging Assays were performed in black 96-well plates (Greiner Bio One). Plates were imaged in a lightproof chamber (IVIS Lumina, Xenogen) equipped with a CCD camera (chilled to -90 °C). The stage was kept at 37 °C during imaging experiments, and the camera was controlled using standard Living Image software. Exposure times ranged from 1 s to 5 min, and data binning levels were set to small or medium. Post-acquisition, regions of interest were selected for quantification. Total flux and radiance values were analyzed using Living Image software or ImageJ (NIH).
Bacterial lysate analysis of luciferase mutants
Bacterial cell stocks (stored in glycerol) containing the mutations of interest (in pET vectors) were streaked on agar plates containing kanamycin. After overnight growth, colonies were picked and expanded overnight. Portions of the cultures (100 µL) were added to 5 mL of LB (kan) and luciferase expression was induced as described previously in Jones, et al. 10 
Substrate unmixing
Substrate unmixing experiments were designed such that a "positive" sample for each enzyme was present in the image to be acquired. For in vitro experiments, "positive" wells comprised pure enzyme. In mouse experiments, "positive" cells were also included as a reference. Images were acquired as a series following each substrate addition. Thus, an image was generated for each enzyme/substrate pair. Linear unmixing was conducted using ImageJ (installed under the FIJI package). Luminescence images containing the raw CCD counts (as TIFF files) were loaded into FIJI and subjected to a 2-pixel median filter to remove any cosmic noise. Next, the signal at each pixel was min-max scaled to lie between 0 and 65535 (the maximum value that can be stored in a 16-bit image). As a result, the brightest pixel in each image had a value of 65535, and the dimmest had a value of 0. Images were then stacked, and an additional image containing the maximum value of each of the stacked images was computed (as a Z projection). This new image was added to the stack, and signals were unmixed using the ImageJ plugin developed by Gammon, et al. 14 In the plugin, regions of interest (ROIs) for each luciferase were drawn around the "pure" areas of the image described above. Each ROI was drawn individually and added to the list by clicking "add." Once all enzymes were added, "Unmix" was used to unmix the images. Pseudocolors were assigned in FIJI through the "Merge Channels" tool.
Mammalian plasmid construction
Pecan-and Cashew-expressing DB7 cells were prepared via CRISPR gene insertion. The relevant luciferase genes (luciferase-G4SX2-FP-T2A-Puro) were amplified and inserted into CRISPR AAVS1 donor plasmids (courtesy of Drs. Theresa Loveless and Chang Liu, UCI). Cashew and Pecan inserts were amplified from pET vectors using the following primers: Antares inserts were amplified with the following primers: Linearized vectors were generated via digestion with restriction enzymes XbaI and XhoI (New England BioLabs). The linearized vectors were combined with the appropriate luciferase insert by Gibson assembly. A portion of the reactions (3.0 µL) was directly transformed into XL1 competent E. coli cells. Sequencing analysis confirmed successful plasmid generation.
Mammalian cell culture and imaging DB7 cells (courtesy of the Contag laboratory, Stanford) were cultured in DMEM (Corning) supplemented with 10% (vol/vol) fetal bovine serum (FBS, Life Technologies), penicillin (100 U/mL), and streptomycin (100 µg/mL). Cells were maintained in a 5% CO 2 water-saturated incubator at 37 °C. To create stable lines expressing mutant luciferases, DB7 cells were transfected with the AAVS1 mutant luciferase donor plasmid, Cas9 (addgene #41815), and AAVS1 sgRNA (addgene #53370) using lipofectamine. The mutant luciferases were integrated into the first locus of AAVS1 through homologous recombination. Transfected cells were then treated with puromycin (20 µg/mL) and FACS sorted at the Institute for Immunology Flow Cytometry Core (UCI).
DB7 cells stably expressing luciferases were added to black 96-well plates (1 x 10 5 cells per well). Stock solutions of 4'-BrLuc and D-luc (5 mM in PBS) were added to each well (250-500 µM final concentration). A solution of furimazine (1:40-1:100 dilution of the commercial stock, Promega) was then added. Sequential imaging was performed as described in the General bioluminescence imaging section (above).
In vivo imaging of orthogonal luciferase-luciferin pairs
Mouse experiments were approved by the UC Irvine Animal Care and Use Committee. FVB/NJ mice (The Jackson Laboratory) received subcutaneous dorsal injections of 1x10 6 DB7 mutant luciferase expressing cells. After 24 h, animals were anesthetized (2% isoflurane) and placed on a warmed (37 °C) stage for imaging. To eliminate movement between injections, one leg of each animal was secured to the imaging platform with black tape. Each mouse received an i.p. injection of luciferin (65 mM, 100 µL per mouse) under the non-secured leg. Images were acquired with 5 min exposure times for 35 min using the General bioluminescence procedure. For sequential imaging, mice were immediately injected with the second substrate and imaged for an additional 35 min. Bioluminescent output was quantified as above. Figure S1 . Identifying intensity resolved orthogonal pairs (a) Mutants considered for rapid BLI with 4'-BrLuc and D-luc. Mutants 50, 51, 53, and 54 prefer 4'-BrLuc, while 37, 85, 86, 87, and 93 prefer D-luc. 11 (b) Candidate luciferases were expressed in bacteria and screened with 100 µM 4'-BrLuc or D-luc. Mutants exhibited orthogonal substrate use, with >10-fold substrate preference observed in most cases. The "winning combination" -mutants 51 and 37 -were also intensity resolved. Error bars represent the standard error of the mean for n = 3 experiments. Figure S2 . Verifying orthogonality and substrate resolution in vivo. DB7 cells expressing different mutant luciferases were implanted into the backs of mice. Sequential application of 4'-BrLuc and D-luc enabled identification of optimal mutant luciferase combinations for multicomponent imaging. Photon flux values from images were quantified and plotted. Mutant luciferases 51 and 37 were identified as optimal candidates for rapid multicomponent BLI. 
Intensity Resolution
The technique described herein for multicomponent bioluminescence imaging via sequential substrate administration also relies on intensity resolution amongst the substrates. In fact, we have found that for the success of the technique, intensity resolution is just as important as substrate resolution. We define intensity resolution as the difference in brightness between two probes. Probes that are intensity resolved enable sequential administration in a single imaging session because the highest possible signal in the probe that is administered first minimally overlaps with the lowest possible signal in the second probe that is administered. If the three probes, p, are administered in sequence (1-3), the total signal intensity, I, from the contributions of each individual probe, i, following each addition can be illustrated as follows:
Where e is the random error associated with each image acquired. In order to be able to resolve all the individual signals, it is necessary that:
When the intensity resolutions (differences) between each probe are large enough that the signal of the previous probe is similar to the error, the signals can be resolved. Written out:
This enables us to eliminate the residual intensity terms from equation 15 to give: 
Any systematic error that is contributed by the previous probe can be eliminated through linear unmixing, described above. Large amounts of intensity overlaps cannot be solved by unmixing, however. If the relationship in the above equation (16) is not true, we risk not having enough information to resolve the individual signals.
